3035-23: Updated Buprenorphine Prescribing Training Requirements for APRNs

4.8 (5 votes)

  • Register
    • Non-member - Free!
    • Regular Member - Free!
    • Retired Member - Free!
    • Affiliate Member - Free!
    • Student Member - Free!

Internet Explorer does not cooperate well with this platform. Please see below for options that work with APNA eLearning Center programs.* 

3035-23: Updated Buprenorphine Prescribing Training Requirements for APRNs

This presentation examines the new training requirements for APRNs who wish to prescribe buprenorphine as outlined by the Consolidated Appropriations Act.This presentation will also explore the Office of National Drug Control Policy’s (ONDCP) proposed curricula for opioid use disorder treatment competency.


Presenters:
  Lauren Meadows, RN; Amanda Simonton, PhD, APRN, PMHNP-BC; Donna Rolin, PhD, APRN, PMHNCS-BC, PMHNP-BC

Disclosures:  The APNA planners and faculty have no relevant financial relationships to disclose. Off-label uses will not be discussed during this presentation.


Session Length:
  30 minutes

Target Audience:  RN, APRN


Learning Outcome:
Upon completion of this presentation, the participant will be able to:

  • Describe current DEA buprenorphine prescribing training requirements. 

Keywords:  Buprenorphine, Opioid Use Disorder, Medications for Opioid Use Disorder


Nursing Continuing Professional Development:
0.5 contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

The American Psychiatric Nurses Association is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.


Price
Free through September 29, 2024 

Grant Statement:

Funding for this initiative was made possible (in part) by grant no. 1H79TI0855888-02 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

image


Access to this course will end:  November 30, 2026


*For an uninterrupted learning experience, please download and use Google ChromeMozilla FirefoxMicrosoft EdgeSafari, etcIf you continue to experience issues, you may need to update your browser.

Components visible upon registration.